<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941221-2-00006</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF COMMERCE</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Foreign-Trade Zones Board</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket 39&hyph;94] </RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Foreign-Trade Zone 149_Freeport, TX; Application for Subzone, Hoffmann-La Roche Inc. (Vitamins and Fine Chemicals), Brazoria County, TX (Freeport Area)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> An application has been submitted to the Foreign-Trade Zones Board (the Board) by the Port of Freeport, Texas, grantee of FTZ 149, requesting special-purpose subzone status for the vitamin and fine chemical manufacturing plant of Hoffmann-La Roche Inc., in Brazoria County, Texas (Freeport area). The application was submitted pursuant to the provisions of the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the regulations of the Board (15 CFR part 400). It was formally filed on November 29, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hoffmann-La Roche Inc. (Roche), is a health care products company with annual revenue of approximately $3 billion in 1993. Its principal businesses include prescription pharmaceuticals, diagnostic products and clinical laboratory testing services, home health care services, vitamins for human and animal nutrition, and animal pharmaceutical products.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Roche's new Freeport production facility (731 acres, 183,920 sq. ft., 11 bldgs.) is located at 1000 County Road 277, Brazoria County, Texas, some 60 miles southeast of Houston. The facility (some 100 employees) is primarily used to produce beta carotene crystalline (previtamin A used in the food processing and pharmaceutical industries). It also produces intermediate chemicals such as C&hyph;25 aldehyde and vinyl salt. At full production nearly 80 percent of the beta carotene crystalline and all of the C&hyph;25 aldehyde and vinyl salt will be exported.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Currently, foreign-sourced materials account for some 36 percent of the finished product value and include the following specific ingredients: Beta ionone, triphenylphosphine and its oxide, C10-dialdehyde, vinylol and etinol.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Zone procedures would exempt Roche from Customs duty payments on foreign materials used in production for export. On domestic sales, the company would be able to choose the duty rates that apply to the finished product (beta carotene crystalline_3.1%). The duty rates on foreign-sourced items used to produce beta carotene crystalline are: Beta ionone, 6.4%; triphenylphosphine, 17.7%; and C10-dialdehyde, 5.6%. The application indicates that the savings from zone procedures will help improve the plant's international competitiveness.  <!-- PJG 0012 frnewline --> In accordance with the Board's regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board's Executive Secretary at the address below. The closing period for their receipt is February 21, 1995. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to March 6, 1995.).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> A copy of the application and accompanying exhibits will be available for public inspection at each of the following locations:  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> U.S. Department of Commerce District Office,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=6 f=1 --> # <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=1 --> 1 Allen Center, Suite 1160,  <!-- PJG 0012 frnewline --> 500 Dallas Street,  <!-- PJG 0012 frnewline --> Houston, Texas 77002  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Office of the Executive Secretary,  <!-- PJG 0012 frnewline --> Foreign-Trade Zones Board,  <!-- PJG 0012 frnewline --> U.S. Department of Commerce,  <!-- PJG 0012 frnewline --> Room 3716,  <!-- PJG 0012 frnewline --> 14th &amp; Pennsylvania Avenue, NW.,  <!-- PJG 0012 frnewline --> Washington, DC 20230 <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: December 13, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> John J. Da Ponte, Jr.,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Executive Secretary.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;31358 Filed 12&hyph;20&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 3510&hyph;DS&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            